Sarah Gheuens, named as one of In Vivo’s Rising Leaders for 2022, leads the R&D department at rare disease company...
Fueled By Connections: Making It Happen In Rare Disease
Agios’s Sarah Gheuens talks to In Vivo about the responsibility of providing new therapies to rare disease populations, building trust with historically underserved communities, and why she loves working with small molecules.
